Therefore, if our hypothesis that downregulation of MMP11 plays an important role in the etiology of HS is correct, it is important to note that the outcome of continuous low-dose BPA exposure with respect to the risk for HS development might be influenced by individual variations of MMP11 expression in response to low-dose BPA. Here, MMP11 is linked to histiocytic sarcoma.